文献速递骨质疏松与代谢性骨病

骨生物力学CT分析(BCT)用于骨质疏松症临床评估

Biomechanical Computed Tomography analysis (BCT) for clinical assessment of osteoporosis.
PubMed 文献 · Osteoporos Int · 2020-04-26

本文综述了骨生物力学CT分析(BCT)的临床应用实现(VirtuOst)、患者管理用途及支持证据。BCT利用患者临床分辨率CT扫描进行有限元分析,测量骨强度及髋部DXA等效骨密度T值和脊柱小梁骨体积骨密度,可识别骨质疏松并评估骨折风险。证据支持BCT作为两性骨质疏松症的准确便捷诊断工具,尤其适合已接受CT检查者的机会性使用。

要点

  • BCT通过有限元分析临床CT扫描测量骨强度和骨密度,无需修改标准CT成像方案。
  • BCT可机会性应用于包含脊柱或髋部的现有CT,无需DXA确认即可识别骨质疏松和评估骨折风险。
  • BCT在诊断骨质疏松和评估骨折风险方面至少与DXA表现相当。

核心结论

  • 证据支持BCT作为两性骨质疏松症的准确便捷诊断测试,尤其适合已接受CT检查患者的机会性使用。

研究设计与样本

  • 本文为综述,描述BCT(VirtuOst)的临床实施、患者管理应用及支持证据。

主要发现

  • BCT提供髋部DXA等效骨密度T值和脊柱小梁骨体积骨密度测量,以及骨强度测量。
  • 基于骨强度和骨密度测量,医生可识别骨质疏松并评估骨折风险(高、增加、未增加),无需DXA确认。
  • BCT在诊断骨质疏松和评估骨折风险方面至少与DXA表现相当。

关键数值与推荐

  • BCT对大多数包含脊柱或髋部区域的现有CT可机会性应用,无需修改标准临床CT成像方案。
  • BCT分析提供髋部DXA等效BMD T-score和脊柱小梁骨体积BMD,结合骨强度可评估骨折风险为高、增加或未增加。

临床怎么用

  • 对无近期DXA但正在或曾因无关医学指征接受包含髋部或脊柱区域CT的患者,可机会性使用BCT诊断骨质疏松和评估骨折风险。
  • 医生可基于BCT的骨强度和BMD测量识别骨质疏松和评估骨折风险,无需DXA确认。

局限性

  • 本文讨论了BCT的主要局限性及临床解读方法,但摘要未具体列出。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The surgeon general of the USA defines osteoporosis as "a skeletal disorder characterized by compromised bone strength, predisposing to an increased risk of fracture." Measuring bone strength, Biomechanical Computed Tomography analysis (BCT), namely, finite element analysis of a patient's clinical-resolution computed tomography (CT) scan, is now available in the USA as a Medicare screening benefit for osteoporosis diagnostic testing. Helping to address under-diagnosis of osteoporosis, BCT can be applied "opportunistically" to most existing CT scans that include the spine or hip regions and were previously obtained for an unrelated medical indication. For the BCT test, no modifications are required to standard clinical CT imaging protocols. The analysis provides measurements of bone strength as well as a dual-energy X-ray absorptiometry (DXA)-equivalent bone mineral density (BMD) T-score at the hip and a volumetric BMD of trabecular bone at the spine. Based on both the bone strength and BMD measurements, a physician can identify osteoporosis and assess fracture risk (high, increased, not increased), without needing confirmation by DXA. To help introduce BCT to clinicians and health care professionals, we describe in this review the currently available clinical implementation of the test (VirtuOst), its application for managing patients, and the underlying supporting evidence; we also discuss its main limitations and how its results can be interpreted clinically. Together, this body of evidence supports BCT as an accurate and convenient diagnostic test for osteoporosis in both sexes, particularly when used opportunistically for patients already with CT. Biomechanical Computed Tomography analysis (BCT) uses a patient's CT scan to measure both bone strength and bone mineral density at the hip or spine. Performing at least as well as DXA for both diagnosing osteoporosis and assessing fracture risk, BCT is particularly well-suited to "opportunistic" use for the patient without a recent DXA who is undergoing or has previously undergone CT testing (including hip or spine regions) for an unrelated medical condition.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Keaveny TM, Clarke BL, Cosman F, et al. Biomechanical Computed Tomography analysis (BCT) for clinical assessment of osteoporosis. Osteoporos Int. 2020. PMID: 32335687. doi:10.1007/s00198-020-05384-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。